Dr. Peter Ainsworth
Adjunct Professor, Director Molecular Diagnostic L
Department of Biochemistry
University of Western Ontario
Canada
Biography
"Dr. Peter Ainsworth is an Adjunct Professor, Director Molecular Diagnostic Laboratory Biochemistry at university of Western Ontario, Canada."
Research Interest
Applications of diagnostic molecular biological techniques in medical genetics make it possible not only to identify carriers of mutations associated with the more classical, clinically identified, inherited diseases such as Cystic Fibrosis, but also to potentially identify specific gene mutations in otherwise well individuals, who may then be considered to be at a higher than average risk of developing disease. This latter development of Predictive Genetics arguably represents the greatest potential area of growth in modern genetics, and will allow the identification of predisposition to a wide variety of mainstream medical conditions, including various cancers, cardiomyopathies, complex metabolic disorders such as diabetes mellitus, disorders of lipid metabolism, as well as a variety of neurologic and psychiatric disorders.
Publications
-
Baker SK, Reith CC, Ainsworth PJ. Novel 95G> A (R32K) somatic mosaic connexin 32 mutation. Muscle & nerve. 2008 Nov 1;38(5):1510-4.
-
Kotsopoulos J, Shen H, Rao AV, Poll A, Ainsworth P, Fleshner N, Narod SA. A BRCA1 mutation is not associated with increased indicators of oxidative stress. Clinical breast cancer. 2008 Dec 1;8(6):506-10.
-
Panchal S, Bordeleau L, Poll A, Llacuachaqui M, Shachar O, Ainsworth P, Armel S, Eisen A, Sun P, Narod SA. Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutationâ€positive families?. Clinical genetics. 2010 Mar 1;77(3):273-9.
